Promotions & Moves

Catalent Biologics Appoints R&D Director

Haskins brings more than 23 years of basic and translational research experience

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Dr. William E. Haskins has been appointed director of R&D, Bioanalytical Chemistry at Catalent Pharma Solutions. Dr. Haskins reports to Dr. David Rabuka, Catalent Biologics’ Global Head of R&D Chemical Biology, and will join the team first formed by Redwood Bioscience, now a part of Catalent Biologics.   He will lead bioanalytical chemistry activities supporting Catalent’s SMARTag technology, a precision protein-chemical engineering technology for the development of advanced antibody-d...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters